Literature DB >> 19604134

The mechanism of dead-in-bed syndrome and other sudden unexplained nocturnal deaths.

B Parekh1.   

Abstract

The mechanism of dead-in-bed syndrome (DBS), a rare but devastating condition that mainly affects young type 1 diabetes patients, remains mysterious. A new theory is proposed to explain this syndrome. This theory suggests that repeated episodes of hypoglycaemia-induced adaptation in orexin-A neurons cause (i) defective awakening and (ii) hypotonia of upper airway muscles during sleep. Consequently, due to the combined effect of these factors, long-term exposure of intermittent hypoxia occurs, leading to a combination of factors - such as depression of ventilation, increase in sympathetic tone, fluctuations in intrathoracic pressure and cardiac arrhythmias - these in conjunction with an underlying cardiovascular pathology (genetically inherited or acquired) cause cardio-respiratory failure and thus sudden death during sleep. This mechanism can be generalized to explain other cases of sudden unexplained nocturnal deaths including sudden infant deaths (SIDs).

Entities:  

Mesh:

Year:  2009        PMID: 19604134     DOI: 10.2174/157339909789804387

Source DB:  PubMed          Journal:  Curr Diabetes Rev        ISSN: 1573-3998


  11 in total

1.  Validation of an Algorithm for Predicting Hypoglycemia From Continuous Glucose Measurements and Heart Rate Variability Data.

Authors:  Simon Lebech Cichosz; Marie Moth Henriksen; Lise Tarnow; Birger Thorsteinsson; Ulrik Pedersen-Bjergaard; Jesper Fleischer
Journal:  J Diabetes Sci Technol       Date:  2019-07-31

Review 2.  Respiration and autonomic regulation and orexin.

Authors:  Eugene Nattie; Aihua Li
Journal:  Prog Brain Res       Date:  2012       Impact factor: 2.453

3.  Combining information of autonomic modulation and CGM measurements enables prediction and improves detection of spontaneous hypoglycemic events.

Authors:  Simon Lebech Cichosz; Jan Frystyk; Lise Tarnow; Jesper Fleischer
Journal:  J Diabetes Sci Technol       Date:  2014-09-12

4.  Role of the carotid body chemoreceptors in baroreflex control of blood pressure during hypoglycaemia in humans.

Authors:  Jacqueline K Limberg; Jennifer L Taylor; Simmi Dube; Rita Basu; Ananda Basu; Michael J Joyner; Erica A Wehrwein
Journal:  Exp Physiol       Date:  2014-01-10       Impact factor: 2.969

5.  Effect of hypoxia on heart rate variability and baroreflex sensitivity during hypoglycemia in type 1 diabetes mellitus.

Authors:  Jacqueline K Limberg; Simmi Dube; Myrthe Kuijpers; Kathryn E Farni; Ananda Basu; Robert A Rizza; Timothy B Curry; Rita Basu; Michael J Joyner
Journal:  Clin Auton Res       Date:  2015-07-04       Impact factor: 4.435

6.  Hypocretin-1 (orexin A) prevents the effects of hypoxia/hypercapnia and enhances the GABAergic pathway from the lateral paragigantocellular nucleus to cardiac vagal neurons in the nucleus ambiguus.

Authors:  O Dergacheva; K Philbin; R Bateman; D Mendelowitz
Journal:  Neuroscience       Date:  2010-12-04       Impact factor: 3.590

7.  Hypoxia and hypercapnia inhibit hypothalamic orexin neurons in rats.

Authors:  Olga Dergacheva; Akihiro Yamanaka; Alan R Schwartz; Vsevolod Y Polotsky; David Mendelowitz
Journal:  J Neurophysiol       Date:  2016-08-24       Impact factor: 2.714

8.  A novel algorithm for prediction and detection of hypoglycemia based on continuous glucose monitoring and heart rate variability in patients with type 1 diabetes.

Authors:  Simon Lebech Cichosz; Jan Frystyk; Ole K Hejlesen; Lise Tarnow; Jesper Fleischer
Journal:  J Diabetes Sci Technol       Date:  2014-03-31

9.  Mortality experience of a low-income population with young-onset diabetes.

Authors:  Baqiyyah N Conway; Michael E May; Lisa B Signorello; William J Blot
Journal:  Diabetes Care       Date:  2012-01-11       Impact factor: 19.112

Review 10.  Sudden Unexplained Nocturnal Death Syndrome: The Hundred Years' Enigma.

Authors:  Jingjing Zheng; Da Zheng; Terry Su; Jianding Cheng
Journal:  J Am Heart Assoc       Date:  2018-03-03       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.